TRETINOIN, gebasaxturev, MK-4280A, vibostolimab, MK-4830, KEYTRUDA 25 mg/mL concentrate for solution for infusion
MK-3475-02C
Phase 2 small_molecule active
Quick answer
TRETINOIN, gebasaxturev, MK-4280A, vibostolimab, MK-4830, KEYTRUDA 25 mg/mL concentrate for solution for infusion for Stage IIIB or IIIC or IIID melanoma is a Phase 2 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Stage IIIB or IIIC or IIID melanoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active